Fund holdings
3.66MShares reported
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Loading…
CVS Health
CVS · NYSE · Pharmacy & insurance
CVS · NYSE · Pharmacy & insurance
Pharmacies, Aetna insurance and care services.
Last close, Oct 1, 2026
$85.20
Adjusted for splits and dividends
Last 12 months
+10.8%
S&P 500 +14.3% over the same dates
Market value
$109B
Last close × shares outstanding
Bets against the stock: 16.1M shares sold short (1.3% of shares outstanding), -11.0% vs the previous count, 3.1 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$402B
+7.8% vs the year before
Net income, fiscal 2025
$1.77B
As reported in the annual filing
Shares outstanding
1.28B
As of Jul 29, 2026
In fiscal 2025 the company spent $3.4B on dividends. Cash actually paid, from its cash-flow statement.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
2 different filers disclosed CVS within 90 days. Disclosed 709 days after the transaction; reported as an official range, not an exact amount.
2 different filers disclosed CVS within 90 days. Disclosed 116 days after the transaction; reported as an official range, not an exact amount.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
A securities lawsuit naming the company as a defendant was filed on Mar 11, 2025 in the Court of Appeals for the First Circuit. A filing is an allegation, not a finding.
In Re: CVS Health Corp. Securities Act Litigation, 25-1230A securities lawsuit naming the company as a defendant was filed on Jul 12, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.
Nixon v. CVS Health Corporation, 1:24-cv-05303Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). 1 case in that period is closed and not listed. Coverage of court records is not complete, and shareholder derivative suits are not included.
Last 12 months, adjusted daily closes
Adjusted close went from $76.87 on Oct 1, 2025 to $85.20 on Oct 1, 2026 (+10.8%). Disclosed trades in the last 12 months: 0 insider purchases, 9 insider sales, 3 Congress purchases, 4 Congress sales.
Fiduciary Duties in Selecting Designated Investment Alternatives
Proposed rule · Employee Benefits Security Administration
United States v. Hewlett Packard Enterprise Co. and Juniper Networks, Inc.; Response of the United States to Public Comments on the Proposed Final Judgments
Notice · Antitrust Division
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
1 notice filed with state agencies, covering 53 workers in total. Employers must warn the state ahead of a plant closing or mass layoff at a site.
Official WARN lists from California, Texas, New York, Florida, Illinois and Washington only; notices filed in other states are not shown. Matched on the employer name as filed, so a notice filed under an unrelated subsidiary name can be missing. Dates are the notice date (Washington: the date the state received it).
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Short sale volume: 34.9% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 41.5%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
Top officer leaving
“Gallina served in the CFO role for Elevance from June 2016 through November 1, 2023, then served as EVP and Advisor to the CEO from November 1, 2023 until May 2024, when he retired.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Congress trade